Discover how Mounjaro the revolutionary weight-loss and diabetes drug by Eli Lilly is set to transform obesity management in ...
Healthcare stocks have gotten crushed in 2024, and next year doesn’t look much better. But there are still opportunities for ...
10h
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
AHA shares feedback in response to the Centers for Medicare & Medicaid Services’ information collection request (ICR) regarding the Medicare Transaction Facilitator (MTF) and the Medicare drug ...
Find out how atogepant, a new migraine medication, offers rapid relief and promotes prevention of migraine attacks. Learn ...
Citi analysts forecast 19% earnings growth for the healthcare sector in 2025 amid improving fundamentals and a boom in weight loss drugs.
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback